DOCSLIB.ORG

ANTIOXIDANT PROPERTIES of FLAXSEED LIGNANS USING in VITRO MODEL SYSTEMS a Thesis Submitted to the College of Graduate Studies A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ANTIOXIDANT PROPERTIES of FLAXSEED LIGNANS USING in VITRO MODEL SYSTEMS a Thesis Submitted to the College of Graduate Studies A ANTIOXIDANT PROPERTIES OF FLAXSEED LIGNANS USING IN VITRO MODEL SYSTEMS A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the College of Pharmacy and Nutrition of the University of Saskatchewan Saskatoon, Saskatchewan Canada By Farah Hosseinian Copyright Farah Hosseinian April 2006 All Rights Reserved The author claims copyright. Use shall not be made of the material contained herein without proper acknowledgment, as indicated on the copyright page. i PERMISION TO USE In presenting this thesis in partial fulfillment of the requirements for a Postgraduate degree from the University of Saskatchewan, I agree that the Libraries of this University may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, for scholarly purposes may be granted by the professor or professors who supervised my thesis work or, in their absence, by the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without permission. It is also understood that due recognition shall be given to me and to the University of Saskatchewan in any scholarly use made of any material in my thesis. Requests for permission to copy or to make other use of material in this thesis, in whole or in parts, should be addressed to: Head College of Pharmacy and Nutrition University of Saskatchewan 110 Science Place Saskatoon, SK S7N 5C9 Canada ii 1.0 ABSTRACT The major objectives of this study were to investigate the antioxidant properties of flaxseed lignans secoisolariciresinol (SECO 2) and secoisolariciresinol diglycoside (SDG 1) and their major oxidative compounds using 2,2'-azobis(2- amidinopropane) dihydrochloride (AAPH 47) in an in vitro model of lipid peroxidation. This investigation was facilitated by the structural elucidation of the major oxidative compounds and the ability of flaxseed lignans to delay the onset of oxidation in two model systems. This study showed that SECO 2 oxidation occurs at the aromatic (4-OH) and aliphatic (9-OH) hydroxyl groups. Conversely for SDG 1, only compounds derived from the oxidation of aromatic hydroxyl groups were obtained because the 9-OH position is glucosylated. SECO 2 oxidation with AAPH 47 showed that the intermediate 2a is most likely involved in the generation of early-forming (48 and 52) and 2c for the formation of late-forming (49, 50 and 51) oxidation compounds. Compound 48 is formed from dimerization of 2a that is converted to 52 and then to 51. Compound 50 was formed by the addition of a carbon-centre free radical of AAPH (AP radical) to 2c. Compounds 50 and 51 trap carbon-centered AP radicals supporting SECO 2 as a chain-breaking antioxidant and AAPH 47 as a proper model for study of SECO 2 oxidation in vitro. iii SDG 1 oxidation with AAPH 47 indicated that intermediates 1b and 1c are most likely involved for the formation of early forming compounds (55 and 58) and 1a leads to the late forming compounds (56 and 57). Compound 55 is a result of dimerization. Compound 56 may be directly formed via intermediate radical 1a by adding AP free radicals. Compound 56 was a stable non-radical compound that could trap AP free radicals, thereby supporting SDG 1 as a chain-breaking antioxidant. Hydrogen abstraction from 4-hydroxyl yielded the radical 1a and hydroxyl radical addition to 1a yielded 57. Compound 58 formed from the addition • of OH or H2O to 1c. This study demonstrated that AAPH 47 produces carbon-centred AP radicals upon thermal decomposition and mimics the formation of lipid peroxyl radicals. Interaction of carbon-centred AP radicals with SECO 2 and SDG 1 provides a good model to study the antioxidant reactions of SECO 2 in vitro. The relative antioxidant capacity of the flaxseed lignans versus BHT 17, in two model systems, was determined. The stoichiometric ratio for SECO 2 and SDG 1 were 1.5 and 1.1-1.2, respectively, compared to BHT 17 (2.0). The induction time by Rancimat analyzer measured inhibition of autoxidation mediated by flaxseed lignans SECO, SDG and SDG polymer in comparison with BHT 17. The induction time data demonstrated that SECO 2 protected canola oil better than either SDG 1 or SDG polymer 3. iv These results are important for better understanding about the chemistry behind flaxseed lignan antioxidant activities. This study provided useful evidence that flaxseed lignans can be used as natural antioxidants. v This thesis is dedicated to……… ….my parents my brother, Vahid my dear husband, Javad and my loving children, Hamed and Saeed vi ACKNOWLEDGEMENTS I would like to sincerely thank my supervisor Dr. Ed. S. Krol for his very kind and generous support, academic advice, as well as his patience, understanding, expertise and criticism in the preparation of this manuscript. I would like to thank the other members of the advisory committee, Drs. J. Alcorn, A.D. Muir, N.D. Westcott and M. Foldvari for their helpful and valuable suggestions during my research work. Sincere thanks to Dr. D. Gorecki, Dr. M. Foldvari and B. Juurlink for their positive encouragement for final preparation of this manuscript. I also thank my parents for their support and understanding. A special thank you goes to my husband Javad, and to my loving children, Hamed and Saeed, for their help, encouragement, and patience during my program. Sincere thanks and appreciation is also extended to Mrs. Krista Thompson and Mrs. Kendra Fesyk for their technical support, Mrs. Sandra Northrup for providing SECO and Mr. Brock Chatson from PBI for providing use of the NMR. I would also to thank Dr. Susan Marles for her useful suggestions during my work and Dr. M. Reaney for the use of the Rancimat apparatus in his lab. Lastly, sincere thank you and gratitude to all of my friends for their support during my stay in Saskatoon living far from my family. I would also to thank the HSURC and SFDC for their financial support and Agriculture and Agri-Food Canada (Saskatoon Research Centre) for the use of the facilities during my program. vii Table of Contents……………………………………………………………....Page PERMISION TO USE.............................................................................................. ii 1.0 ABSTRACT..................................................................................................iii ACKNOWLEDGEMENTS ................................................................................... vii 2.0. LITERATURE REVIEW ............................................................................ 1 2.1. Flaxseed, general description...................................................................... 1 2.2. Flaxseed oil................................................................................................. 1 2.3. Flaxseed mucilage....................................................................................... 2 2.4. Flaxseed lignans.......................................................................................... 2 2.4.1. Properties of SECO 2 and SDG 1 ....................................................... 5 2.4.1.1. Optical rotation of SECO 2 and SDG 1 .......................................... 6 2.5. Mammalian lignans..................................................................................... 8 2.5.1. Conversion of plant lignans to mammalian lignans............................ 8 2.5.2. Role of gut flora in the oxidation of plant lignans to mammalian lignans................................................................................................. 9 2.6. Hepatic metabolism of mammalian lignans.............................................. 12 2.6.1. Phase I metabolism ........................................................................... 12 2.6.2. Phase 2 metabolism........................................................................... 12 2.7. Flaxseed lignan uptake and urinary levels ................................................ 15 2.8. Flaxseed lignan uptake and plasma levels ................................................ 16 2.9. Flaxseed health benefits............................................................................ 17 2.9.1. ALA in flaxseed - health benefits ..................................................... 18 2.9.1.1. ALA: Animal studies .................................................................... 18 2.9.1.2. ALA: Human studies .................................................................... 18 2.9.1.3. Mechanism of action..................................................................... 20 2.9.2. Mucilage - health benefits................................................................. 20 2.9.3. Flaxseed lignans – health benefits .................................................... 21 2.9.3.1. Animal studies.............................................................................. 22 2.9.3.2. Human studies............................................................................... 23 2.9.3.3. In vitro studies............................................................................... 25 2.9.3.4. Correlation between in vitro production and in vivo excretion of lignans........................................................................................... 26 2.10. Lignan- mechanism of effect ................................................................ 27 2.10.1. Non-hormonal mechanisms .............................................................
Load more

Recommended publications
  • Chemoprotective Effects of Flaxseed Lignans Enterodiol And
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Texas A&M Repository CHEMOPROTECTIVE EFFECTS OF FLAXSEED LIGNANS ENTERODIOL AND ENTEROLACTONE IN NON-TRANSFORMED COLONOCYTES A Thesis by CHRISTINA ALISON CURRY Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Chair of Committee, Clinton Allred Committee Members, Joseph Awika Jenna Anding Head of Department, Boon Chew December 2015 Major Subject: Nutrition Copyright 2015 Christina Alison Curry ABSTRACT Previous epidemiological studies have shown that colon cancer incidence is correlated to diet and estrogen status. Phytoestrogens are molecules with similar structures to estrogen that occur naturally in plants. There is in vitro and in vivo evidence that phytoestrogens in the diet can inhibit carcinogenesis. The phytoestrogenic mammalian lignans enterolactone (EL) and enterodiol (ED) in flaxseed have been shown to be effective in decreasing tumor incidence in carcinogenic models, but there is little data regarding their effects in non-malignant cells. The following studies used a non- transformed cell line of young adult mouse colonocytes (YAMC) to determine the protective effects of ED and EL in chemoprevention. Our results demonstrate that low levels of EL (1µM) and ED (5µM) are effective at significantly reducing cell growth and increasing apoptosis. These treatments also regulated transcription via significant differences in gene levels related to apoptosis and cell cycle progression. The data collected demonstrate some of the physiological effects of EL and ED on the cellular and molecular level.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. N0.: US 2014/0221426 A1 Gerk Et Al
    US 20140221426A1 (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2014/0221426 A1 Gerk et al. (43) Pub. Date: Aug. 7, 2014 (54) SELECTIVE METABOLIC APPROACH TO A61K 31/216 (2006.01) INCREASING ORAL BIOAVAILABILITY OF A61K 31/09 (2006.01) PHENYLEPHRINE AND OTHER PHENOLIC A61K 31/05 (2006.01) BIOACTIVITIES A61K 31/353 (2006.01) A61K 31/4525 (2006.01) (71) Applicant: VIRGINIA COMMONWEALTH A61 K 31/3 75 (2006.01) UNIVERSITY, Richmond, VA (US) A61K 31/121 (2006.01) _ _ _ (52) US. Cl. (72) Inventorsl Ph_lll_lP M- Gerk’ Rthmond, VA (Us); CPC ........... .. A61K 31/137 (2013.01); A61K 31/3 75 Wllllam H- Fa", R10hm°nda VA (Us); (2013.01); A61K 31/235 (2013.01); A61K J"sellh K- thter’ Rlchmond, VA (Us) 31/11 (2013.01); A61K 31/085 (2013.01); _ A61K 31/121 (2013.01); A61K 31/09 (21) APP1~ NO" 14/345,689 (2013.01); A61K31/05 (2013.01); A61K . _ 31/353 (2013.01);A61K31/4525 (2013.01); (22) PCT Filed. Sep. 27, 2012 A61K31/216 (201301) USPC ......... .. 514/321' 514/653' 514/474' 514/544' ( 86 ) PCT N 0 .: PCT/U52012/057588 ’ ’ 514/456;’ 514/532’ § 371 (0X1), Related US“ Application Data Presystemic metabolism in intestine of bioactives such as (60) Provisional application No. 61/539,530, ?led on Sep. phenylephrine 1? avoided by administering a Sllbject (human 27, 2011, provisional application No. 61/544,396, 0r 21111111211) the bloactlve(e-g-,Pheny1ephr1ne)1n comblnatlon ?led on Oct 7, 201 1_ With one or more inhibitors of sulfation (e.g., sulfotransferase enzymes aka SULTs).
    [Show full text]
  • Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem
    Supplementary materials Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim, Injae Song, Yen T. K. Nguyen, Suckchang Hong, Byung Woo Han, Ho-Young Lee - 1 - Table S1. Short tandem repeat (STR) DNA profiles for human cancer cell lines used in this study. MDA-MB-231 Marker H1299 H460 A549 HCT116 (MDA231) Amelogenin XX XY XY XX XX D8S1179 10, 13 12 13, 14 10, 14, 15 13 D21S11 32.2 30 29 29, 30 30, 33.2 D7S820 10 9, 12 8, 11 11, 12 8 CSF1PO 12 11, 12 10, 12 7, 10 12, 13 D3S1358 17 15, 18 16 12, 16, 17 16 TH01 6, 9.3 9.3 8, 9.3 8, 9 7, 9.3 D13S317 12 13 11 10, 12 13 D16S539 12, 13 9 11, 12 11, 13 12 D2S1338 23, 24 17, 25 24 16 21 D19S433 14 14 13 11, 12 11, 14 vWA 16, 18 17 14 17, 22 15 TPOX 8 8 8, 11 8, 9 8, 9 D18S51 16 13, 15 14, 17 15, 17 11, 16 D5S818 11 9, 10 11 10, 11 12 FGA 20 21, 23 23 18, 23 22, 23 - 2 - Table S2. Antibodies used in this study. Catalogue Target Vendor Clone Dilution ratio Application1) Number 1:1000 (WB) ADI-SPA- 1:50 (IHC) HSP70 Enzo C92F3A-5 WB, IHC, IF, IP 810-F 1:50 (IF) 1 :1000 (IP) ADI-SPA- HSP90 Enzo 9D2 1:1000 WB 840-F 1:1000 (WB) Oct4 Abcam ab19857 WB, IF 1:100 (IF) Nanog Cell Signaling 4903S D73G4 1:1000 WB Sox2 Abcam ab97959 1:1000 WB ADI-SRA- Hop Enzo DS14F5 1:1000 WB 1500-F HIF-1α BD 610958 54/HIF-1α 1:1000 WB pAkt (S473) Cell Signaling 4060S D9E 1:1000 WB Akt Cell Signaling 9272S 1:1000 WB pMEK Cell Signaling 9121S 1:1000 WB (S217/221) MEK Cell Signaling 9122S 1:1000
    [Show full text]
  • Phytoestrogens : Daidzein, Enterodiol, Enterolactone, Equol, Geinstein, O-Desmethylangolensin Matrix: Urine Method: HPLC-ESI-MS/MS Method No: 4069.03
    Laboratory Procedure Manual Analyte: Phytoestrogens : Daidzein, Enterodiol, Enterolactone, Equol, Geinstein, O-Desmethylangolensin Matrix: Urine Method: HPLC-ESI-MS/MS Method No: 4069.03 Revised: March 2018 as performed by: Nutritional Biomarkers Branch (NBB) Division of Laboratory Sciences (DLS) National Center for Environmental Health (NCEH) contact: James L. Pirkle, M.D., Ph.D. Director, Division of Laboratory Sciences Important Information for Users CDC periodically refines these laboratory methods. It is the responsibility of the user to contact the person listed on the title page of each write-up before using the analytical method to find out whether any changes have been made and what revisions, if any, have been incorporated. Phytoestrogen NHANES 2013-2014 This document details the Lab Protocol for testing the items listed in the following table. This method file describes measurements of U1PHYTO_H_R and U2PHYTO_H_R. One method was used to measure both the 24 hour urine phytoestrogen, 1st urine collection and 24 hour urine phytoestrogen, 2nd urine collection. However, these results are released as 2 separate data files. Variable File Name SAS Label (and SI units) Name Daidzein, Urine 1st collection UR1DAZ (ng/mL) o-Desmethylangolensin, Urine 1st UR1DMA Collection (ng/mL) UR1EQU Equol, Urine 1st Collection (ng/mL) Enterodiol, Urine 1st Collection UR1ETD (ng/mL) Enterolactone, Urine 1st Collection UR1ETL (ng/mL) Genistein, Urine 1st Collection UR1GNS (ng/mL) U1PT_H_R Daidzein, Urine 2nd collection U2PT_H_R UR2DAZ (ng/mL) o-Desmethylangolensin, Urine 2nd UR2DMA Collection (ng/mL) UR2EQU Equol, Urine 2nd Collection (ng/mL) Enterodiol, Urine 2nd Collection UR2ETD (ng/mL) Enterolactone, Urine 2nd Collection UR2ETL (ng/mL) Genistein, Urine 2nd Collection UR2GNS (ng/mL) 2 of 54 Phytoestrogen NHANES 2013-2014 1.
    [Show full text]
  • Trans-Resveratrol [501-36-0]
    trans-Resveratrol [501-36-0] Review of Toxicological Literature March 2002 trans-Resveratrol [501-36-0] Review of Toxicological Literature Prepared for Scott Masten, Ph.D. National Institute of Environmental Health Sciences P.O. Box 12233 Research Triangle Park, North Carolina 27709 Contract No. N01-ES-65402 Submitted by Karen E. Haneke, M.S. Integrated Laboratory Systems P.O. Box 13501 Research Triangle Park, North Carolina 27709 March 2002 Toxicological Summary for trans-Resveratrol [501-36-0] 03/2002 Executive Summary Nomination trans-Resveratrol was nominated for toxicology studies by the National Institute of Environmental Health Sciences (NIEHS) based on the widespread human exposure to resveratrol through natural dietary sources and dietary supplement use, and concern that it has not been sufficiently evaluated for potential toxicological effects. Non-Toxicological Data General Description: trans-Resveratrol is a polyphenol that occurs naturally in grapes, peanuts, and a number of other plants. It is found in foods/drinks made from grapes and peanuts, and also in a number of herbal remedies, both alone and as part of plant extracts. Commercial Availability, Production, and Uses: trans-Resveratrol is produced commercially by several companies. A commercial extraction method involves using alcohol and water to produce trans­ resveratrol from Polygonum cuspidatum. Resveratrol compounds may be produced or extracted for research purposes by treating cell suspension cultures of grapes with a natural substance from a fungus. Resveratrol compounds have long been found in herbal medicines. Health claims of oral dietary supplements containing trans-resveratrol include protection from free-radical damage, inhibition of arthritic inflammation, inhibition of the cyclooxygenase-2 enzyme, protection of blood vessels, protection against cardiovascular disease and cancer, and alleviation of menopausal symptoms.
    [Show full text]
  • Urinary and Serum Concentrations of Seven Phytoestrogens in a Human Reference Population Subset
    Journal of Exposure Analysis and Environmental Epidemiology (2003) 13, 276–282 r 2003 Nature Publishing Group All rights reserved 1053-4245/03/$25.00 www.nature.com/jea Urinary and serum concentrations of seven phytoestrogens in a human reference population subset LIZA VALENTI´ N-BLASINI, BENJAMIN C. BLOUNT, SAMUEL P. CAUDILL, AND LARRY L. NEEDHAM National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA Diets rich in naturally occurring plant estrogens (phytoestrogens) are strongly associated with a decreased risk for cancer and heart disease in humans. Phytoestrogens have estrogenic and, in some cases, antiestrogenic and antiandrogenic properties, and may contribute to the protective effect of some diets. However, little information is available about the levels of these phytoestrogens in the general US population. Therefore, levels of phytoestrogenswere determined in urine (N ¼ 199) and serum (N ¼ 208) samples taken from a nonrepresentative subset of adults who participated in NHANES III, 1988– 1994. The phytoestrogens quantified were the lignans (enterolactone, enterodiol, matairesinol); the isoflavones (genistein, daidzein, equol, O- desmethylangolensin); and coumestrol (urine only). Phytoestrogens with the highest mean urinary levels were enterolactone (512 ng/ml), daidzein(317 ng/ ml), and genistein (129 ng/ml). In serum, the concentrations were much less and the relative order was reversed, with genistein having the highest mean level (4.7 ng/ml), followed by daidzein (3.9 ng/ml) and enterolactone (3.6 ng/ml). Highly significant correlations of phytoestrogen levels in urineand serum samples from the same persons were observed for enterolactone, enterodiol, genistein, and daidzein. Determination of phytoestrogen concentrations in large study populations will give a better insight into the actual dietary exposure to these biologically active compounds in the US population.
    [Show full text]
  • Asian Journal of Medical Sciences 1 (2010) 20-25
    Asian Journal of Medical Sciences 1 (2010) 20-25 ASIAN JOURNAL OF MEDICAL SCIENCES Hepato-protective Potential of Hull Fraction from Indian Flaxseed Cultivar J. Rajesha1*, A. Ranga Rao3, M. Karuna Kumar2 and G. A. Ravishankar3 1Department of Biochemistry, Yuvaraja’s College and 2Department of Studies in Biochemistry, University of Mysore, Mysore. 570005, India. 3Plant Cell Biotechnology Department, Central Food Technological Research Institute, Mysore 570020,India. Abstract Objective: Secoisolariciresinol diglucoside (SDG) isolated from hull fraction of Indian flaxseed cultivar was studied for its hepatoprotective potential by measuring the level of hepatic enzymes such as catalase, peroxidase and superoxide desmutase (SOD) upon feeding to albino rats. Material & Methods: The animals were grouped into five groups (n=5): The first group served as normal and received normal diet without treatment of toxin and hull fraction of flaxseed. The second group was named the control and received a regular commercial diet. The third, fourth and fifth groups were fed with normal diet and supplemented with hull fraction of flaxseed (150 and 250 μg/kg) and standard SDG (150 μg/kg), that was mixed with olive oil for 14 days. Results: Pretreatment of rats with 150 µg/kg b.w hull fraction of flaxseed followed by CCl4 treatment caused restoration of catalase, SOD and peroxidase by 37.70%, 108.22% and 23.89% respectively as compared to control. The group treated with 250 µg/kg b.w hull fraction of flaxseed showed the restoration of 67.30%, 152.82% and 39.88% of catalase, SOD and peroxidase, respectively. Conclusion: In conclusion, SDG fed in the form of flaxseed hull is responsible for its hepatoprotective properties.
    [Show full text]
  • Analytical Reference Standards
    Cerilliant Quality ISO GUIDE 34 ISO/IEC 17025 ISO 90 01:2 00 8 GM P/ GL P Analytical Reference Standards 2 011 Analytical Reference Standards 20 811 PALOMA DRIVE, SUITE A, ROUND ROCK, TEXAS 78665, USA 11 PHONE 800/848-7837 | 512/238-9974 | FAX 800/654-1458 | 512/238-9129 | www.cerilliant.com company overview about cerilliant Cerilliant is an ISO Guide 34 and ISO 17025 accredited company dedicated to producing and providing high quality Certified Reference Standards and Certified Spiking SolutionsTM. We serve a diverse group of customers including private and public laboratories, research institutes, instrument manufacturers and pharmaceutical concerns – organizations that require materials of the highest quality, whether they’re conducing clinical or forensic testing, environmental analysis, pharmaceutical research, or developing new testing equipment. But we do more than just conduct science on their behalf. We make science smarter. Our team of experts includes numerous PhDs and advance-degreed specialists in science, manufacturing, and quality control, all of whom have a passion for the work they do, thrive in our collaborative atmosphere which values innovative thinking, and approach each day committed to delivering products and service second to none. At Cerilliant, we believe good chemistry is more than just a process in the lab. It’s also about creating partnerships that anticipate the needs of our clients and provide the catalyst for their success. to place an order or for customer service WEBSITE: www.cerilliant.com E-MAIL: [email protected] PHONE (8 A.M.–5 P.M. CT): 800/848-7837 | 512/238-9974 FAX: 800/654-1458 | 512/238-9129 ADDRESS: 811 PALOMA DRIVE, SUITE A ROUND ROCK, TEXAS 78665, USA © 2010 Cerilliant Corporation.
    [Show full text]
  • 1.25 Lignans: Biosynthesis and Function
    1.25 Lignans: Biosynthesis and Function NORMAN G. LEWIS and LAURENCE B. DAVIN Washington State University, Pullman, WA, USA 0[14[0 INTRODUCTION 539 0[14[1 DEFINITION AND NOMENCLATURE 539 0[14[2 EVOLUTION OF THE LIGNAN PATHWAY 531 0[14[3 OCCURRENCE 534 0[14[3[0 Li`nans in {{Early|| Land Plants 534 0[14[3[1 Li`nans in Gymnosperms and An`iosperms "General Features# 536 0[14[4 OPTICAL ACTIVITY OF LIGNAN SKELETAL TYPES AND LIMITATIONS TO THE FREE RADICAL RANDOM COUPLING HYPOTHESIS 536 0[14[5 707? STEREOSELECTIVE COUPLING] DIRIGENT PROTEINS AND E!CONIFERYL ALCOHOL RADICALS 541 0[14[5[0 Diri`ent Proteins Stipulate Stereoselective Outcome of E!Coniferyl Alcohol Radical Couplin` in Pinoresinol Formation 541 0[14[5[1 Clonin` of the Gene Encodin` the Diri`ent Protein and Recombinant Protein Expression in Heterolo`ous Systems 543 0[14[5[2 Sequence Homolo`y Comparisons 543 0[14[5[3 Comparable Systems 543 0[14[5[4 Perceived Biochemical Mechanism of Action 546 0[14[6 PINORESINOL METABOLISM AND ASSOCIATED METABOLIC PROCESSES 547 0[14[6[0 Sesamum indicum] "¦#!Piperitol\ "¦#!Sesamin\ and "¦#!Sesamolinol Synthases 547 0[14[6[1 Magnolia kobus] Pinoresinol and Pinoresinol Monomethyl Ether O!Methyltransferase"s# 550 0[14[6[2 Forsythia intermedia and Forsythia suspensa 551 0[14[6[2[0 "¦#!Pinoresinol:"¦#!lariciresinol reductase 552 0[14[6[2[1 "−#!Secoisolariciresinol dehydro`enase 554 0[14[6[2[2 Matairesinol O!methyltransferase 556 0[14[6[3 Linum usitatissimum] "−#!Pinoresinol:"−#!Lariciresinol Reductase and "¦#!Secoisolariciresinol Glucosyltransferase"s# 557
    [Show full text]
  • 3. Food Chemistry & Biotechnology 3.1. Lectures
    Chem. Listy, 102, s265–s1311 (2008) Food Chemistry & Biotechnology 3. FOOD CHEMISTRY been femented for 10 days at 10 °c under semiaerobic condi- & BIOTECHNOLOGY tions or 4–6 weeks at 10 °c under anaerobic conditions. Second cultivation medium: the sterile vinea drinks were inoculated by studied yeast strains and cultuivated at 3.1. Lectures 20 °c for 10 days under semiaerobic conditions. the samples were than sensorially evaluated by a group L01 NONSACCHAROMYCES YEAST IN GRAPE of degustators. the same samples were than analysed by gas MUST – ADVANTAGE OR SPOILAGE? chromatography for the aroma compounds production. each sample was analysed on the Gc MS (Shimadzu QP 2010) JAROSLAVA Kaňuchová PátKováa, EMÍLIA equipment and also on the Gc FiD equipment (Gc 8000 ce Breierováb and INGRID vajcziKová instruments). aInstitute for viticulture and enology of SARC two methods of sample preparation were done: Matuškova 25, 831 01 Bratislava, Slovak republic, the samples (20 ml) were extracted by ether (2 ml), and bInstitute of ChemistrySAS, Dúbravská cesta 9, 845 38 Brati- centrifuged prior to analysis. the etheric extract was used for slava, Slovak republic, analysis (liquid – liquid extraction). this method was used [email protected] for higher alcohols (propanol, isoamylacohol, ethyl ester and higher alcoholos esters) determination Introduction the samples were extracted by tenaq (solid phase mic- the fresh grape must consists of spontaneous microf- roextraction) and than 10 min sampling according to6. this lora formed from 90 to 99 % by yeasts. the most important method was used for monoterpenic compounds determina- genus is without doubt Saccharomyces cerevisiae which is tion.the same column and the same conditions were used by responsible for successive fermentation and good wine qua- both analysis: column: DB WaX 30 m, 0.25 × 0.25, tempe- lity.
    [Show full text]
  • Molecular Targets of Natural Products for Chondroprotection in Destructive Joint Diseases
    International Journal of Molecular Sciences Review Molecular Targets of Natural Products for Chondroprotection in Destructive Joint Diseases Thanasekaran Jayakumar 1, Periyakali Saravana Bhavan 2 and Joen-Rong Sheu 1,3,* 1 Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; [email protected] 2 Department of Zoology, Bharathiar University, Coimbatore 641046, Tamil Nadu, India; [email protected] 3 Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan * Correspondence: [email protected]; Tel.: +886-2-27361661-3199; Fax: +886-27390450 Received: 16 June 2020; Accepted: 8 July 2020; Published: 13 July 2020 Abstract: Osteoarthritis (OA) is the most common type of arthritis that occurs in an aged population. It affects any joints in the body and degenerates the articular cartilage and the subchondral bone. Despite the pathophysiology of OA being different, cartilage resorption is still a symbol of osteoarthritis. Matrix metalloproteinases (MMPs) are important proteolytic enzymes that degrade extra-cellular matrix proteins (ECM) in the body. MMPs contribute to the turnover of cartilage and its break down; their levels have increased in the joint tissues of OA patients. Application of chondroprotective drugs neutralize the activities of MMPs. Natural products derived from herbs and plants developed as traditional medicine have been paid attention to, due to their potential biological effects. The therapeutic value of natural products in OA has increased in reputation due to their clinical impact and insignificant side effects. Several MMPs inhibitor have been used as therapeutic drugs, for a long time. Recently, different types of compounds were reviewed for their biological activities.
    [Show full text]
  • Synthetic Secoisolariciresinol Diglucoside Attenuates Established Pain, Oxidative Stress and Neuroinflammation in a Rodent Model
    antioxidants Article Synthetic Secoisolariciresinol Diglucoside Attenuates Established Pain, Oxidative Stress and Neuroinflammation in a Rodent Model of Painful Radiculopathy Sonia Kartha 1, Christine L. Weisshaar 1, Ralph A. Pietrofesa 2, Melpo Christofidou-Solomidou 2 and Beth A. Winkelstein 1,3,* 1 Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected] (S.K.); [email protected] (C.L.W.) 2 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected] (R.A.P.); [email protected] (M.C.-S.) 3 Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA * Correspondence: [email protected] Received: 18 October 2020; Accepted: 25 November 2020; Published: 30 November 2020 Abstract: Painful cervical radiculopathy is characterized by chronic neuroinflammation that lowers endogenous antioxidant responses leading to the development of oxidative stress and pain after neural trauma. Therefore, antioxidants such as secoisolariciresinol diglucoside (SDG), that promote antioxidant signaling and reduce oxidative damage may also provide pain relief. This study investigated if repeated systemic administration of synthetic SDG after a painful root compression reduces the established pain, oxidative stress and spinal glial activation that are typically evident. SDG was administered on days 1–3 after compression and the extent of oxidative damage in the dorsal root ganglia (DRG) and spinal cord was measured at day 7 using the oxidative stress markers 8-hydroxguanosine (8-OHG) and nitrotyrosine. Spinal microglial and astrocytic activation were also separately evaluated at day 7 after compression. In addition to reducing pain, SDG treatment reduced both spinal 8-OHG and nitrotyrosine, as well as peripheral 8-OHG in the DRG.
    [Show full text]